Small Molecule Drug Synthesis Platform
Led by overseas returnee postdoctors, the core members of the synthesis team boast profound technical accumulation in pharmaceutical process R&D and total synthesis of natural products, and are fully capable of custom synthesis of complex and highly challenging compounds. This platform provides end-to-end support for the full-process process development and large-scale production of chemically synthesized drug molecules from preclinical research, clinical stages to commercialization. It can deliver customized process development services for starting materials, pharmaceutical intermediates and final drug substances of various small molecule drugs.
Core Deliverables
Various customized drug impurities
High-difficulty drug impurity compounds that conform to the corresponding structures and meet the standard requirements for impurity research and determination, with delivery quantities covering the full range from milligram level to kilogram level.
Pharmaceutical Intermediates at All Stages
High-difficulty drug impurity compounds that conform to the corresponding structures and meet the standard requirements for impurity research and determination, with delivery quantities covering the full range from milligram level to kilogram level.
Small molecule building blocks for new drugs
Small molecule building blocks corresponding to different targets, which meet the needs of innovative drug research and can support the requirements of global new drug application.
ISO 17034
ISO 17025
 |
No. 3 Hanshan Road, Xuejia Town, Xinbei District, |
 |
+86-0519-88910898 |
 |
sales@xianglongpharm.com |
Call us
No. 3 Hanshan Road, Xuejia Town, Xinbei District,Changzhou, Jiangsu Province, China
+86-0519-88910898
sales@xianglongpharm.com